Do decision-analytic models identify cost-effective treatments? A retrospective look at helicobacter pylori eradication.

Journal of managed care pharmacy : JMCP

Volumn 9, Issue 5, 2003, Pages 430-440

  Fairman, Kathleen A ^a   Motheral, Brenda R ^a  

^a Express Script Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE;

ARTICLE; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DRUG EFFECT; ECONOMICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PHARMACOECONOMICS; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ANTI-INFECTIVE AGENTS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ECONOMICS, PHARMACEUTICAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; MODELS, ECONOMIC; RETROSPECTIVE STUDIES;

EID: 0642378141     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2003.9.5.430     Document Type: Article

References (0)